TY - JOUR
T1 - Indwelling central venous catheter infection with Chryseobacterium shandongense – successful eradication in a 5-year-old with cystic fibrosis
AU - Rowan, Anthony
AU - Verbruggen, Tiarnan Fallon
AU - O'connell, Nuala H.
AU - Stapleton, Patrick J.
AU - Dunne, Colum P.
AU - Linnane, Barry
AU - Butler, Daryl
N1 - Publisher Copyright:
© 2023 The Authors.
PY - 2023
Y1 - 2023
N2 - Introduction. Chryseobacterium shandongense is a Gram-negative Flavobacterium bacillus with intrinsic multidrug-resistant properties. Case Presentation. Herein, we present the first case report of human C. shandongense infection, relating to an implantable portal and catheter (port-a-cath) central line in a 5-year-old female with cystic fibrosis. The infection was identified using a Bruker MALDI-TOF Biotyper with BDAL (v12) of blood, which was cultured due to pyrexia and rigour following port-a-cath access. This report details the effective eradication of C. shandongense infection from the port-a-cath device using initial empirical gentamicin followed by targeted ciprofloxacin locks and systemic antibiotics. Conclusion. We demonstrated successful eradication of C. shandongense from a port-a-cath device, including the minimum inhibitory concentrations (MICs) required in this case. The result was eradication of central access infection, preventing pro-gression to bacteraemia/septicaemia and preserving central access in a child with cystic fibrosis and established respiratory disease.
AB - Introduction. Chryseobacterium shandongense is a Gram-negative Flavobacterium bacillus with intrinsic multidrug-resistant properties. Case Presentation. Herein, we present the first case report of human C. shandongense infection, relating to an implantable portal and catheter (port-a-cath) central line in a 5-year-old female with cystic fibrosis. The infection was identified using a Bruker MALDI-TOF Biotyper with BDAL (v12) of blood, which was cultured due to pyrexia and rigour following port-a-cath access. This report details the effective eradication of C. shandongense infection from the port-a-cath device using initial empirical gentamicin followed by targeted ciprofloxacin locks and systemic antibiotics. Conclusion. We demonstrated successful eradication of C. shandongense from a port-a-cath device, including the minimum inhibitory concentrations (MICs) required in this case. The result was eradication of central access infection, preventing pro-gression to bacteraemia/septicaemia and preserving central access in a child with cystic fibrosis and established respiratory disease.
KW - Chryseobacterium shandongense
KW - cystic fibrosis
KW - port-a-cath infection
UR - http://www.scopus.com/inward/record.url?scp=85217664200&partnerID=8YFLogxK
U2 - 10.1099/acmi.0.000700.v3
DO - 10.1099/acmi.0.000700.v3
M3 - Article
AN - SCOPUS:85217664200
SN - 2516-8290
VL - 5
JO - Access Microbiology
JF - Access Microbiology
IS - 12
M1 - 000700.v3
ER -